Aclaris: Q4 Earnings Snapshot

Audio By Carbonatix

WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Tuesday reported a loss of $1.5 million in its fourth quarter.

The Wayne, Pennsylvania-based company said it had a loss of 2 cents per share. Losses, adjusted for non-recurring gains, came to 30 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 37 cents per share.

The specialty pharmaceutical company posted revenue of $17.6 million in the period, also surpassing Street forecasts. Six analysts surveyed by Zacks expected $4 million.

For the year, the company reported that its loss widened to $88.5 million, or $1.27 per share. Revenue was reported as $31.2 million.

The company's shares closed at $1.21. A year ago, they were trading at $12.07.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACRS at https://www.zacks.com/ap/ACRS